SNCA Stock Price, News & Analysis

SNCA NASDAQ

Company Description

SNCA (NASDAQ: SNCA) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

SNCA stock has gained 114.7% over the past year.

This page provides a comprehensive overview of SNCA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+114.69%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

SNCA (SNCA) stock. Over the past 12 months, the stock has gained 114.7%.

Latest News

View All

April 26, 2021

+6.33%

Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.

acquisition

April 12, 2021

-5.06%

Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Date of April 23, 2021

March 30, 2021

+10.07%

Seneca Stockholder Letter

March 27, 2021

-3.87%

Seneca Special Meeting Q&A

March 24, 2021

-6.49%

Seneca Announces New Special Meeting Date of April 9, 2021

March 23, 2021

-1.98%

Seneca Biopharma Reports 2020 Yearend Results

SNCA has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, clinical trial. View all SNCA news →

SEC Filings

View All

No SEC filings available for SNCA.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SNCA Company Profile & Sector Positioning

SNCA (SNCA) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.